Molecular subtyping improves prognostication of Stage 2 colorectal cancer
R. V. Purcell, S. Schmeier, Y. C. Lau, J. F. Pearson, F. A. Frizelle
This study compares TNM staging to molecular subtyping in Stage 2 colorectal cancer, finding that adding subtyping improves prognostication for certain subtypes.
bioRxiv · Jun 20, 2019Cancer Biology